332 related articles for article (PubMed ID: 15286358)
1. A race to the starting line.
Vogel G
Science; 2004 Jul; 305(5684):632-5. PubMed ID: 15286358
[No Abstract] [Full Text] [Related]
2. [Doping: effectiveness, consequences, prevention].
Guezennec CY
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
[TBL] [Abstract][Full Text] [Related]
3. Are drugs winning the games?
Sullivan R; Song S
Time; 2000 Sep; 156(11):90-2. PubMed ID: 11067230
[No Abstract] [Full Text] [Related]
4. Doping in the recombinant era: strategies and counterstrategies.
Azzazy HM; Mansour MM; Christenson RH
Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
[TBL] [Abstract][Full Text] [Related]
5. A half-century of anabolic steroids in sport.
Bowers LD; Clark RV; Shackleton CH
Steroids; 2009 Mar; 74(3):285-7. PubMed ID: 19428435
[No Abstract] [Full Text] [Related]
6. Gene doping.
Haisma HJ; de Hon O
Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
[TBL] [Abstract][Full Text] [Related]
7. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
Rogol AD
Pediatr Exerc Sci; 2014 Nov; 26(4):423-7. PubMed ID: 25372376
[No Abstract] [Full Text] [Related]
8. [Hormonal substances used as ergogenic agents].
Laudo Pardos C; Puigdevall Gallego V; del Río Mayor MJ
Med Clin (Barc); 1999 Jan; 112(2):67-73. PubMed ID: 10065435
[No Abstract] [Full Text] [Related]
9. Stay alert for performance-enhancing substance use.
Jarvi JF
JAAPA; 2004 Dec; 17(12):36-9. PubMed ID: 15631019
[No Abstract] [Full Text] [Related]
10. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
Rogol AD
Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
[TBL] [Abstract][Full Text] [Related]
11. Rogue athletes and recombinant DNA technology: challenges for doping control.
Azzazy HM; Mansour MM
Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
[TBL] [Abstract][Full Text] [Related]
12. [Doping and urologic tumors].
Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
[TBL] [Abstract][Full Text] [Related]
13. Medicine and science in the fight against doping in sport.
Catlin DH; Fitch KD; Ljungqvist A
J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
[TBL] [Abstract][Full Text] [Related]
14. OMICS-strategies and methods in the fight against doping.
Reichel C
Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
[TBL] [Abstract][Full Text] [Related]
15. [Use of anabolic androgenic steroids, growth hormone and erythropoietin by patients in general practice].
Keld DB; Hahn T
Ugeskr Laeger; 2006 Sep; 168(37):3121-4. PubMed ID: 16999915
[TBL] [Abstract][Full Text] [Related]
16. What price the Olympian ideal?
Abbott A
Nature; 2000 Sep; 407(6801):124-7. PubMed ID: 11001030
[No Abstract] [Full Text] [Related]
17. Use and abuse of anabolic and other drugs for athletic enhancement.
Catlin DH; Hatton CK
Adv Intern Med; 1991; 36():399-424. PubMed ID: 1673818
[No Abstract] [Full Text] [Related]
18. Commentary on Graham et al.: physical effects of short-term rhGH administration in abstinent steroid dependency.
Sonksen PH; Holt RI
Horm Res; 2008; 69(6):355-6. PubMed ID: 18504394
[No Abstract] [Full Text] [Related]
19. [Identification of candidate genes and expression profiles, as doping biomarkers].
Paparini A; Impagnatiello F; Pistilli A; Rinaldi M; Gianfranceschi G; Signori E; Stabile AM; Fazio V; Rende M; Romano Spica V
Ann Ig; 2007; 19(4):303-14. PubMed ID: 17937323
[TBL] [Abstract][Full Text] [Related]
20. Doping, gene transfer and sport.
Verma IM
Mol Ther; 2004 Sep; 10(3):405. PubMed ID: 15336640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
